A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area

Journal of Urology

Volumn 129, Issue 1, 1983, Pages 56-61

  Soloway, M S ^a   Beckley, S ^a   Brady, M F ^a   Chu, T M ^b   deKernion, J B ^b   Dhabuwala, C ^b   Gaeta, J F ^b   Gibbons, R P ^b   Loening, S A ^b   McKiel, C F ^b   McLeod, D G ^b   Pontes, J E ^b   Prout, G R ^b   Scardino, P T ^b   Schlegel, J U ^b   Schmidt, J D ^b   Scott, W W ^b   Slack, N H ^b   Murphy, G P ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ESTRAMUSTINE;

ADVERSE DRUG REACTION; ANOREXIA; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; DRUG COMPARISON; DRUG THERAPY; EDEMA; GASTROINTESTINAL TOXICITY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MAJOR CLINICAL STUDY; MALE GENITAL SYSTEM; METASTASIS; NAUSEA; NEPHROTOXICITY; PROSTATE CARCINOMA; RADIOTHERAPY; THERAPY; UREMIA; VOMITING;

EID: 0020680663     PISSN: 00225347     EISSN: None     Source Type: None    
DOI: 10.1016/S0022-5347(17)51917-5     Document Type: Article

References (15)

1. G.P. Murphy R.P. Gibbons D.E. Johnson S.A. Loening G.R. Prout J.D. Schmidt D.S. Bross T.M. Chu J.F. Gaeta J. Saroff W.W. Scott A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation J. Urol. 118 1977 288
2. G.P. Murphy R.P. Gibbons D.E. Johnson G.R. Prout J.D. Schmidt M.S. Soloway S.A. Loening T.M. Chu J.F. Gaeta J. Saroff Z. Wajsman N.H. Slack W.W. Scott The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation J. Urol. 121 1979 763
3. M.S. Soloway J.B. deKernion R.P. Gibbons D.E. Johnson S.A. Loening J.E. Pontes G.R. Prout Jr. J.D. Schmidt W.W. Scott T.M. Chu J.F. Gaeta N.H. Slack G.P. Murphy Comparison of estramustine phosphate and vincristine alone or in combination for patients with advanced, hormone refractory, previously irradiated carcinoma of the prostate J. Urol. 125 1981 664
4. S. Madajewicz R. Catane A. Mittelman Z. Wajsman G.P. Murphy Chemotherapy of advanced, hormonally resistant prostatic carcinoma Oncology 37 1980 53
5. D.J. Higby H.J. Wallace Jr. D.J. Albert J.F. Holland Diamminodichloroplatinum: a phase I study showing responses in testicular and other tumors Cancer 33 1974 1219
6. C. Merrin Treatment of advanced carcinoma of the prostate (stage D) with infusion of cis-diamminedichloroplatinum (II NSC 119875): a pilot study J. Urol. 119 1978 522
7. C.E. Merrin S. Beckley Treatment of estrogen-resistant stage D carcinoma of prostate with cis diamminedichloroplatinum Urology 13 1979 267
8. G.P. Murphy N.H. Slack Response criteria for the prostate of the USA National Prostatic Cancer Project Prostate 1 1980 375
9. T.M. Chu M.C. Wang R. Kuciel L. Valenzuela G.P. Murphy Enzyme markers in human prostatic carcinoma Cancer Treat. Rep. 61 1977 193
10. Z. Wajsman T.M. Chu D. Bross J. Saroff G.P. Murphy D.E. Johnson W.W. Scott R.P. Gibbons G.R. Prout J.D. Schmidt Clinical significance of serum alkaline phosphatase isoenzyme levels in advanced prostatic carcinoma J. Urol. 119 1978 244
11. S.J. Cutler F. Ederer Maximum utilization of the life table method in analyzing survival J. Chron. Dis. 8 1958 699
12. G.W. Snedecor W.G. Cochran Statistical Methods 6th ed 1967 Iowa State University Press Ames, Iowa
13. R. Peto J. Peto Asymptomatically efficient rank invariant procedures J. Roy. Stat. Soc. A 135 1972 185
14. D.R. Cox Some simple approximate tests for Poisson variates Biometrika 40 1953 354
15. D.E. Johnson W.W. Scott R.P. Gibbons G.R. Prout J.D. Schmidt T.M. Chu J.F. Gaeta J. Saroff G.P. Murphy National randomized study of chemotherapeutic agents in ad vanced prostatic carcinoma: a progress report Cancer Treat. Rep. 61 1977 317